tiprankstipranks
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA

ImmunoPrecise Antibodies (IPA) Ownership - Who Owns ImmunoPrecise Antibodies?

120 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 06, 2024
Mitch Levine
Chairman,director
Bought$14256
Mar 28, 2024
Jennifer Lynne Bath
President & Chief Executive Officer
Bought$13892
Mar 27, 2024
Kristin Taylor
Interim Chief Financial Officer
Bought$7650
Mar 26, 2024
Jennifer Lynne Bath
President & Chief Executive Officer
Bought$4470

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,056,500Insider23.02%5,995,935
4,509,630Insider17.14%4,464,534
4,468,613Insider16.98%4,423,927
4,330,433Insider16.46%4,287,129
4,078,000Insider15.50%4,037,220
1,565,865Insider5.95%1,550,206
1,565,865Insider5.95%1,550,206
1,240,400Insider4.71%1,227,996
788,200Insider3.00%780,318
473,220Insider1.80%468,488

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
17,484Institution0.07%17,309
8,224Institution0.03%8,142

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns ImmunoPrecise Antibodies (IPA)?
Currently, no data Available
What percentage of ImmunoPrecise Antibodies (IPA) stock is held by institutional investors?
Currently, no data Available
What percentage of ImmunoPrecise Antibodies (IPA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of ImmunoPrecise Antibodies (IPA)?
Gabriele Miss owns the most shares of ImmunoPrecise Antibodies (IPA).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis